130 related articles for article (PubMed ID: 29330482)
1. Normal karyotype in myelofibrosis: is prognostic integrity affected by the number of metaphases analyzed?
Nicolosi M; Mudireddy M; Gangat N; Pardanani A; Hanson CA; Ketterling RP; Tefferi A
Blood Cancer J; 2018 Jan; 8(1):8. PubMed ID: 29330482
[No Abstract] [Full Text] [Related]
2. Monosomal karyotype in primary myelofibrosis is detrimental to both overall and leukemia-free survival.
Vaidya R; Caramazza D; Begna KH; Gangat N; Van Dyke DL; Hanson CA; Pardanani A; Tefferi A
Blood; 2011 May; 117(21):5612-5. PubMed ID: 21450904
[TBL] [Abstract][Full Text] [Related]
3. Karyotype complements the International Prognostic Scoring System for primary myelofibrosis.
Hussein K; Huang J; Lasho T; Pardanani A; Mesa RA; Williamson CM; Ketterling RP; Hanson CA; Van Dyke DL; Tefferi A
Eur J Haematol; 2009 Apr; 82(4):255-9. PubMed ID: 19215287
[TBL] [Abstract][Full Text] [Related]
4. Isochromosome 17q in a case of myelofibrosis with myeloid metaplasia terminating in blastic transformation.
Nakamura H; Sadamori N; Yamada Y; Yao E; Tagawa M; Nishino K; Sasagawa I; Kamihira S; Oyakawa Y; Tomonaga M
Cancer Genet Cytogenet; 1987 Feb; 24(2):221-4. PubMed ID: 3791175
[TBL] [Abstract][Full Text] [Related]
5. Multiple chromosomal changes and karyotypic evolution in a patient with myelofibrosis.
Trautmann U; Rubbert A; Gramatzki M; Henschke F; Gebhart E
Cancer Genet Cytogenet; 1992 Jul; 61(1):6-10. PubMed ID: 1638481
[TBL] [Abstract][Full Text] [Related]
6. Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients.
Tefferi A; Jimma T; Gangat N; Vaidya R; Begna KH; Hanson CA; Van Dyke DL; Caramazza D; Pardanani A
Blood; 2011 Oct; 118(17):4595-8. PubMed ID: 21881047
[TBL] [Abstract][Full Text] [Related]
7. Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients.
Caramazza D; Begna KH; Gangat N; Vaidya R; Siragusa S; Van Dyke DL; Hanson C; Pardanani A; Tefferi A
Leukemia; 2011 Jan; 25(1):82-8. PubMed ID: 20944670
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system.
Dupriez B; Morel P; Demory JL; Lai JL; Simon M; Plantier I; Bauters F
Blood; 1996 Aug; 88(3):1013-8. PubMed ID: 8704209
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.
Strasser-Weippl K; Steurer M; Kees M; Augustin F; Tzankov A; Dirnhofer S; Fiegl M; Simonitsch-Klupp I; Gisslinger H; Zojer N; Ludwig H
Cancer; 2006 Dec; 107(12):2801-6. PubMed ID: 17103442
[TBL] [Abstract][Full Text] [Related]
10. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
Gangat N; Caramazza D; Vaidya R; George G; Begna K; Schwager S; Van Dyke D; Hanson C; Wu W; Pardanani A; Cervantes F; Passamonti F; Tefferi A
J Clin Oncol; 2011 Feb; 29(4):392-7. PubMed ID: 21149668
[TBL] [Abstract][Full Text] [Related]
11. Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia.
Tefferi A; Meyer RG; Wyatt WA; Dewald GW
Br J Haematol; 2001 Nov; 115(2):316-9. PubMed ID: 11703327
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS.
de Swart L; Smith A; Haase D; Fenaux P; Symeonidis A; Cermak J; Sanz G; Stauder R; Mittelman M; Hellström-Lindberg E; Malcovati L; Langemeijer S; Skov-Holm M; Mądry K; Germing U; Almeida AM; Tatic A; Savic A; Šimec NG; van Marrewijk C; Guerci-Bresler A; Sanhes L; Luño E; Culligan D; Beyne-Rauzy O; Burgstaller S; Blijlevens N; Bowen D; de Witte T
Leuk Res; 2018 Apr; 67():21-26. PubMed ID: 29407183
[TBL] [Abstract][Full Text] [Related]
13. Derivative (1)t(1;19)(p13;p13) in the setting of myelofibrosis with JAK2 V617F.
Staropoli JF; Wadleigh M; Dal Cin P
Cancer Genet Cytogenet; 2009 Jun; 191(2):109-10. PubMed ID: 19446748
[No Abstract] [Full Text] [Related]
14. MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis.
Tefferi A; Guglielmelli P; Lasho TL; Gangat N; Ketterling RP; Pardanani A; Vannucchi AM
J Clin Oncol; 2018 Jun; 36(17):1769-1770. PubMed ID: 29708808
[No Abstract] [Full Text] [Related]
15. Multiple active X chromosomes in myelofibrosis with myeloid metaplasia.
Van Dyke DL; Abraham JP; Maeda K; Weiss L; Poel M
Cancer Genet Cytogenet; 1981 Mar; 3(2):137-44. PubMed ID: 7272992
[TBL] [Abstract][Full Text] [Related]
16. The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosis.
Tefferi A; Lasho TL; Mudireddy M; Finke CM; Hanson CA; Ketterling RP; Gangat N; Pardanani A
Am J Hematol; 2019 Mar; 94(3):299-305. PubMed ID: 30516848
[TBL] [Abstract][Full Text] [Related]
17. Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisons.
Mudireddy M; Shah S; Lasho T; Barraco D; Hanson CA; Ketterling RP; Gangat N; Pardanani A; Tefferi A
Br J Haematol; 2018 Aug; 182(4):594-597. PubMed ID: 28677834
[No Abstract] [Full Text] [Related]
18. Karyotypic abnormalities in myelofibrosis following polycythemia vera.
Andrieux J; Demory JL; Caulier MT; Agape P; Wetterwald M; Bauters F; Laï JL
Cancer Genet Cytogenet; 2003 Jan; 140(2):118-23. PubMed ID: 12645649
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia.
Tefferi A; Mesa RA; Schroeder G; Hanson CA; Li CY; Dewald GW
Br J Haematol; 2001 Jun; 113(3):763-71. PubMed ID: 11380468
[TBL] [Abstract][Full Text] [Related]
20. A case of acute myelofibrosis with complex karyotypic changes: a type of myelodysplastic syndrome.
Allen EF; Lunde JH; McNally R; Branda RE
Cancer Genet Cytogenet; 1996 Aug; 90(1):24-8. PubMed ID: 8780742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
